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Summary We have used the polymerase chain reaction to detect DNA sequences related to human
papillomavirus type 16, by simultaneous priming with oligonucleotides from the E6 and LI/L2 open reading
frames of the HPV16 genome. The HPV16-related sequence is present at low levels in normal oral tissue, in
addition to biopsies and cell cultures from patients with benign and malignant disease. Ultimate analysis of
the amplified sequences from the E6(120bp) and Ll/L2(173bp) regions of HPV16 was achieved by gel
electrophoresis and comparative nucleotide sequencing. The oral carcinoma biopsies and tissue cultures
contained DNA sequences which were identical to the E6 region of HPV16, but only rarely contained
sequences closely related to the L1/L2 region. The PCR technology should permit the detection, identification
and cloning of latent viruses from extremely small tissue biopsies.
Epidemiological studies have implied that an infectious agent
may play a role in human oral cancer (reviewed by Scully et
al., 1988). A similar association has been noted between
human cervical cancer and a specific infectious agent, namely
human papillomavirus (HPV), in particular HPV type 16
(Howley, 1986). In the United Kingdom, up to 80% of
invasive cervical carcinomas probably contain HPV16 DNA
(reviewed in Munoz et al., 1988) hence the implication of
HPV16 as an aetiological agent in the disease. In oral
lesions, HPV antigens and genes have been detected, princi-
pally in benign papillary lesions (Loning et al., 1985), but
also in carcinoma tissue (de Villiers et al., 1985). Our own
studies (Scully et al., 1987; Maitland et al., 1987a) indicated
that a HPV, closely related to HPV16, was present as DNA
at low levels in oral tissue types, ranging from histologically
normal through benign leukoplakia to invasive carcinoma. If
an aetiological role for HPV is proposed in oral cancer, it is
necessary to determine the incidence of the virus in the
affected population and to follow the interactions between
HPV and the oral epithelium. Detailed epidemiological
study, in contrast to simple screening, requires either large
amounts of material or more sensitive techniques than those
presently available, and it was with these aims in mind that
the present work was undertaken.
First, to overcome the shortage of material, we have
established keratinocyte cultures from oral squamous cell
carcinoma tissue according to the method described by
Rheinwald and Green (1975) and modified by Crane et al.
(1986 and manuscript in preparation). Secondly, we have
developed the polymerase chain reaction (PCR), as originally
described for the detection of point mutations in haemo-
globinopathies and cellular oncogenes (Chehab et al., 1987;
Saiki et al., 1986, 1988; Bos et al., 1987). The PCR depends
on the in vitro amplification of small segments of DNA,
located between oligonucleotide primers of known DNA
sequence. Using this technology we can detect a single copy
of the HPV genome in 104 uninfected cells, or in a biopsy of
only 25 cells (Young et al., unpublished manuscript). The
use of PCR and oligonucleotide hybridisation to detect HPV
DNA in histological sections of human cervical carcinoma
has recetly been published (Shibata et al., 1988). Using
primers located in the E6 gene, which is preferentially
retained and expressed in cervical carcinoma, and LI/L2
overlap region of HPV16 (Seedorf et al., 1985; Smotkin &
Wettstein, 1986) we provide further evidence, at the nucleo-
tide base sequence level, that human oral tissues and tissue
cultures contain the 'cervical' HPV type 16 DNA.
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Materials and methods
Source of tissues and cell cultures
Cubes of freshly frozen (in liquid N2) tissue biopsies were
obtained from the Bristol Dental Hospital (oral samples),
Birmingham Maternity Hospital (cervical cancers) and Bris-
tol Royal Infirmary (cervical smears). Duplicated indepen-
dent histological analysis was obtained for all the oral and
cervical cancer samples. The oral tumours reported here were
all classified as well differentiated squamous cell carcinomas.
In all cases the tissue extracted for DNA was adjacent to
that from which frozen sections were cut for histology to
minimise the effects of tissue heterogeneity on the extracted
material.
Keratinocyte cultures were established from human oral
squamous cell carcinoma tissue, and passaged without clon-
ing as described by Crane et al. (1986) for rat oral squamous
cell carcinoma tissue. DNA was extracted from healthy
subconfluent cultures at various passages after initial estab-
lishment as a primary culture (see below). Cell cultures of
CaSki were obtained from the ATCC.
Extraction and purification of DNA
Nucleic acids (both DNA and RNA) were extracted accord-
ing to a variation of the method of Chirgwin et al. (1979) as
previously described (Maitland et al., 1987b) from all of the
tissue cultures and biopsies. Briefly, this involved homogeni-
sation of the tissue in a detergent/guanidinium thiocyanate
mixture, followed by ultracentrifugation for 16h through a
double cushion of caesium trifluoroacetate (Pharmacia)
containing ethidium bromide. DNA formed a u.v. fluor-
escent band between the two cushions, whereas the RNA
formed a solid pellet at the bottom of the centrifuge tube.
This modification allows the maximum information to be
obtained from a small (1 mm3) tissue biopsy.
Polymerase chain reaction
PCR was carried out essentially according to the manufac-
turer's instructions for 30 cycles of denaturation (30 s at
910C), annealing (30s at 250C) and synthesis (5min at 550C)
in a buffer containing 16.6mM ammonium sulphate, 67mM
Tris.HCl pH 8.8, 6.7mM MgCl2, 10mM mercaptoethanol,
6.7 M ethylene diamine tetraacetic acid (EDTA), 33jM each
of dATP, dCTP, dGTP and dTTP, 10% dimethylsulphoxide
(DMSO), 0.5-1.0 g of human DNA target and 300ng of
each primer DNA (the reaction will work with considerably
lower primer concentrations) in a final volume of 50p1. After
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the reaction mixture is prepared, and the first denaturation
(7min at 91°C) completed, 1 unit of Taq DNA polymerase
(Anglian Biotec) was added and the annealing, synthesis and
denaturation were carried out for 10 cycles, when a second 1
unit of Taq polymerase was added. After 20 cycles a further
I unit of the polymerase was added and the cycles continued
up to 30. After this time half of the reaction products were
removed, 1/10 volume of gel loading dye (0.25% bromo-
phenol blue, 0.25% xylene cyanole, 25% Ficoll 400) was
added to each and the samples were analysed on a polyacry-
lamide gel (12%) prepared in Tris/borate buffer (89mM Tris-
borate, 89mM boric acid, pH 7.8) by electrophoresis at
45mA for 60min. The final amplified oligonucleotide pro-
ducts were visualised by ethidium bromide stain (1 ugml
in Tris/borate buffer) and ultraviolet illumination.
18
Nucleotide sequence analysis of PCR products
The 298bp amplification product from the E6 gene primers
2 and 3 was purified from a 12% polyacrylamide gel by
excision of the band, overnight elution in an excess of
0.1 xTE buffer at 37°C and centrifuge driven dialysis on a
centricon 30 (Amicon) as described in Higuchi et al. (1988).
The 4041 product of this was freeze dried, resuspended in up
to 8pl of ddH20 and approximately half of this (depending
on the yield) was transcribed in vitro, using T7 RNA
polymerase (Davanaloo et al., 1984). Sequencing of the in
vitro transcripts was carried out with dideoxynucleotide
nucleotide triphosphates and avian myeloblastosis virus
reverse transcriptase (Pharmacia) exactly as described by
Stoflet et al. (1988), using a 32P end-labelled primer 2.
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Figure 1 Oligonucleotide primer sequences and locations on the HPV16 genome (adapted from Seedorf et al., 1985) (a) E6 gene
primers, (b) LI/L2 overlap region primers, (c) T7 polymerase sequencing primer position in the E6 gene.
Results
Standard polymerase chain reaction on oral tissue DNA
using HPV16 E6 gene primers
One microgram of DNA from a number of different tissues
and lesion types was subjected to the standard PCR at 55°C.
We selected the E6 region of the HPV16 genome for
amplification, and in particular a 120bp fragment located
close to the 3' terminus as shown in Figure la. The expected
120bp amplification product was visualised by ultraviolet
illumination of the ethidium bromide stained polyacrylamide
gel (Figure 2), except in the fetal kidney and the carcinoma
culture 145(6). The negative result with 145(6) was in
contrast to the positive result with 145(8). However, reampli-
fication of the non-visualised products from 145(6) resulted
in a weak positive result. Since 145(6) is an earlier passage of
145(8), it implies that selection of HPV16 positive cells may
occur in vitro.
DNA sequence analysis of PCR products from the E6 region
Preliminary comparative analysis of the PCR products from
oral and cervical tissues was carried out with the restriction
endonucleases shown in Figure la (data not shown). Since
the amounts of DNA obtained from a single PCR were close
to the limits required for convincing restriction endonuclease
analysis, we were anxious to confirm the identity of the
DNA amplified by the E6 primers as HPV16 at the ultimate
level, i.e. that of the sequence of the nucleotide bases in this
region. Initial experiments, in which the 120bp E6 amplifica-
tion products were directly sequenced with the sequenase
system, produced disappointing results with material ampli-
fied from oral samples (whereas cervical samples gave correct
sequences according to Seedorf et al. (1985) for both the E6
and L1/L2 genes). The lack of success with oral samples was
attributed to the poor yields of PCR product and, to amplify
these products further, we employed a third E6 primer,
which was homologous to a 20 base sequence, 5' to the
original primer 1. Attached to the HPV16 portion of this
primer was a 28 base sequence, encoding the T7 phage RNA
polymerase promoter (Davanaloo et al., 1984). After purifi-
cation of the 298bp amplification product of this reaction, it
was therefore possible to amplify the products by in vitro
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Figure 2 Polymerase chain reaction with E6 primers 1 and 2.
Reactions were performed on purified DNA from the sources
indicated with the synthesis step carried out at 55°C. Analysis of
the products was by 12% polyacrylamide gel electrophoresis. The
position of molecular weight marker is shown arrowed on the
left of the figure.
transcription. Sequencing was accomplished with AMV
reverse transcriptase from end-labelled primer 2 (Stoflet et
al., 1988). The results of a sequencing of one oral sample,
and an HPV16 positive cervical carcinoma biopsy control
are shown in Figure 3. Over the entire legible range, the two
sequences were identical (the locations of primer 1 and the
restriction endonuclease sites from Figure 1 are also
indicated).
l
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Figure 3 Nucleotide sequence analysis of E6 amplification pro-
ducts from oral and cervical carcinoma DNA. Sequencing was
carried out on the 298bp product of a PCR with E6 primers 2
and 3 (see Figure lc). The end-labelled sequencing primer was
primer 2. The position of primer 1 in the determined sequence,
and the restriction endonuclease cleavage sites from Figure la
are also indicated.
Polymerase chain reaction on oral DNA samples using
LJ/L2 primers
To test whether the late regions of the HPV16 sequence were
present in the oral tissues, we employed primers synthesised
from the overlap region between the LI and L2 regions
(Figure lb). The results of the PCR with these primers are
shown in Figure 4. Positive controls with CaSki DNA and
cloned HPV16 DNA were positive for both the early and
late primers separately and on simultaneous priming with all
four oligonucleotides, to give the expected 120 and 173bp
amplification products respectively. Similar results were
obtained with other cervical tumour DNA samples which
contained considerably lower amounts (one to two genomes
per cell) of HPV 16 DNA per cell (data not shown). In
contrast, DNA from the oral tissues and cultures was
positive only for the E6 diagnostic fragment, even under the
less stringent reaction conditions, with the possible exception
of culture H157(17) and SCC biopsy 1, which were weakly
positive with the L1/L2 primers. In our experience, this
implies an extremely low level of late genes, perhaps in a
small number of the cells in the biopsy or culture, whereas
early genes are present in the majority of the cells. In some
of the oral samples, a number of low molecular weight
bands (<80bp) were detected. However, these bands failed
to react with a HPV16 DNA probe (data not shown).
Multiple low molecular weight bands of this nature were
often observed, particularly when several sets of primers
were employed simultaneously, but a positive reaction was
only scored when the amplification product predicted from
the published DNA sequence was observed.
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Figure 4 Simultaneous polymerase chain ractions using primers
for E6 and LI/L2 regions on oral carcinoma culture and biopsy
DNA. Analysis of the PCR products was carried out on a 12%
polyacrylamide gel. Predicted sizes of the amplification products
are shown arrowed on the left.702 N.J. MAITLAND et al.
Discussion
Our previous results (Scully et al., 1987; Maitland et al.,
1987a) indicated that papillomavirus DNA, closely related
to, but not identical to that from the potentially oncogenic
cervical HPV type 16, could be detected in nucleic acid
preparations from a number of oral lesions, including
cancers. To further explore the nature of the oral variant of
HPV16, we produced cultures from the tumour tissues, but
even in these uncloned keratinocyte cultures, detection of
HPV DNA was technically difficult. The weak signals could
have been due to nucleotide base sequence differences
between the cervical HPV16, which we used as a hybridisa-
tion probe, and the related oral virus. Equally, the positive
results could have resulted from cross-hybridisation between
human DNA sequences and the viral probe. By employing
the PCR we were able to produce unequivocally positive
results, in almost 50% of oral carcinomas tested, even with
the smallest oral tissue biopsies. This value is entirely in
agreement with our earlier results (Maitland et al., 1987a).
An alternative explanation for the consistently poor
signals obtained in experiments to detect HPV in oral tissues
may lie in the distribution of viral DNA positive cells in the
cultures and the biopsies. In some of the oral keratinocyte
cultures the strength of the PCR signal for HPV16 E6 varied
with the passage number of the cultures, implying selection
for HPV-positive cells with time in culture. It is likely that
an uneven distribution of HPV positive cells does occur,
both in vivo and in vitro, based on this result and also on in
situ hybridisations to HPV16 positive tissue sections (unpub-
lished observations).
The design of oligonucleotide primers for the PCR tech-
nique used in this study was based on our previous results
(Maitland et al., 1987a). The E6 gene sequences are consis-
tently retained in both cervical and oral carcinomas (Baker
et al., 1987; Smotkin & Wettstein, 1986; N. Maitland,
unpublished data), whereas the late genes (LI/L2) are often
deleted in cervical carcinomas when the HPV16 genome is
integrated into the cell genome. In addition, only a very
small proportion of the oral samples in our previous study
contained detectable HPV16 late genes.
Using this combination of oligonucleotide primers the
results again bore out those of our previous work, in that
early genes were readily detected, whereas the late genes were
freqently absent in oral tissues. Confirmation of the identity
of the viral DNA present in the oral tissues was achieved by
direct nucleotide sequencing of a portion of the E6 gene.
Employing a third primer from this gene and in vitro
transcription from the T7 phage RNA polymerase promoter,
sufficient HPV template for nucleotide sequencing was pro-
duced. The sequencing indicated that the oral and cervical
HPV16 E6 genes were, as predicted from the restriction
endonuclease digestions, identical over the 120bp amplified
in the initial experiments, including the primer 1 sequence. It
is perhaps significant in view of the essential role of E6 gene
expression in tumours that the E6 genes from a total of nine
oral and nine cervical HPV16 positive samples sequenced to
date show no sequence variations (manuscript in
preparation).
Unfortunately, we are still unable to determine, on the
basis of either the Southern blotting or the PCR results,
whether the frequently negative result with the late region
primers is due to lack of these sequences, or to gross
sequence divergence, which would make both annealing of
high complexity probes in Southern blotting or low com-
plexity oligonucleotide primers for the PCR unlikely. The
detection of multiple low molecular weight bands in the
simultaneous E6 and LI/L2 priming (Figure 4) experiments
probably represents self-priming of the cellular DNA, but
could equally be the result of viral genome rearrangements.
The failure of these 'ladders' to hybridise to an HPV16
probe argues in favour of the former explanation, however.
If the late regions were completely absent, then the oral
(sequences' would not represent a viable virus.
The resolution of these two possibilities requires cloning of
the HPV16 homologous sequences from the oral cultures,
which will provide the required amounts of DNA. Using the
amplified sequence for the E6 region as an homologous
hybridisation probe, we are now able to clone the entire
HPV16-related sequence and to determine its role in oral
diseases, including cancer.
The use of the PCR has overcome some of the extreme
difficulties experienced in the analysis, at the molecular level,
of extremely small tissue samples and heterogeneous primary
cell cultures. The technique should also assist in epidemiolo-
gical studies of virus incidence, without the compromises in
sensitivity which are often necessary in the handling of large
sample numbers.
We wish to thank Cliff Jeal and Sue Hagan for their excellent
assistance with matters photographic, and Caroline Lynas for assis-
tance with developing and running the PCR. This work was
supported by the Cancer Research Campaign.
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